Package 51662-1375-2

{"route": ["INTRAVENOUS"], "spl_id": "e9fd11b6-5cbd-ba83-e053-2a95a90a42af", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0363323739119"], "unii": ["5QZO15J2Z8"], "rxcui": ["1743833"], "spl_set_id": ["9948991d-9405-c7c8-e053-2995a90a60ca"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 VIAL, SINGLE-DOSE (51662-1375-1)", "package_ndc": "51662-1375-1", "marketing_start_date": "20191209"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1375-2)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1375-2", "marketing_start_date": "20221001"}], "brand_name": "FAMOTIDINE", "product_id": "51662-1375_e9fd11b6-5cbd-ba83-e053-2a95a90a42af", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "51662-1375", "generic_name": "FAMOTIDINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FAMOTIDINE", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "10 mg/mL"}], "application_number": "ANDA075813", "marketing_category": "ANDA", "marketing_start_date": "20191209", "listing_expiration_date": "20261231"}